Disc Medicine IRON Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Disc Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Disc Medicine's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Disc Medicine's investing cash flow?
- Disc Medicine (IRON) reported investing cash flow of $58.31M in Q1 2026.
- How has Disc Medicine's investing cash flow changed year-over-year?
- Disc Medicine's investing cash flow increased by 121.4% year-over-year, from -$272.63M to $58.31M.
- What is the long-term trend for Disc Medicine's investing cash flow?
- Over 2 years (2022 to 2024), Disc Medicine's investing cash flow has grown at a 4300.0% compound annual growth rate (CAGR), from -$151K to -$292.33M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.